Clinical trial
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
NCT00229775 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- July 31, 2008
- Enrollment
- 560 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.